Long et al. and Qu et al. indicated that critical COVID-19 patients had higher IgM and IgG antibody responses than non-critical patients [20, 21] due to a high level of viral load or inflammatory storm in severe or critical cases [22]. The gene discussed is CD40LG; the disease is COVID-19.